ProCE Banner Activity

Patient Education PDF on Key Decisions in HIV Care: Start Now With Rapid ART

PDF
Download this PDF to share with your patients newly diagnosed with HIV who are considering rapid initiation of ART.

Released: February 28, 2022

Expiration: February 27, 2023

No longer available for credit.

Share

Faculty

Jason Schafer

Jason Schafer, PharmD, MPH

Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Jason Schafer, PharmD, MPH

Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Jason Schafer, PharmD, MPH, has disclosed that he has received consulting fees from Merck, Viiv, and Theratechnologies and funds for research support from Gilead and Merck.